**Question:** A 62-year-old man reports early satiety, fatigue, and generally feeling unwell. On examination he has a large spleen, appears pale, and the rest of the examination is normal. His blood count is abnormal; the WBC is 50,000/mL with increased mature granulocytes, hemoglobin 9.5 g/dL, and platelets 450,000/mL. Which of the following cytogenetic changes is most characteristic of his condition?

A. Chronic myeloid leukemia (CML)
B. Acute myeloid leukemia (AML)
C. Acute lymphoblastic leukemia (ALL)
D. Myelodysplastic syndrome (MDS)

**Correct Answer:**

**Core Concept:**

Chromosome abnormalities are genetic alterations that can lead to various hematological disorders. In this case, we are looking for a specific cytogenetic change that is characteristic of the patient's symptoms and signs.

**Why the Correct Answer is Right:**

The patient's symptoms, examination findings, and abnormal blood counts (WBC 50,000/mL, mature granulocytes, low hemoglobin 9.5 g/dL, and increased platelets 450,000/mL) are consistent with a myeloproliferative disorder rather than a lymphoid or myelodysplastic disorder. Chronic myeloid leukemia (CML) is a clonal disorder of hematopoietic stem cells where a reciprocal translocation occurs between chromosomes 9 and 22, resulting in the fusion of BCR (breakpoint cluster region) and ABL (Abelson) genes. This results in the BCR-ABL fusion protein, which is a tyrosine kinase enzyme that drives the disease process.

**Why Each Wrong Option is Invalid:**

A. Acute myeloid leukemia (AML) is a clonal disorder of hematopoietic stem cells characterized by rapid cell growth, differentiation arrest, and blast cell infiltration in the bone marrow and blood. While AML can present with similar symptoms and blood counts, the correct answer is CML due to the specific chromosomal abnormality and BCR-ABL fusion protein.

B. Acute lymphoblastic leukemia (ALL) is a clonal disorder of lymphoid progenitor cells characterized by rapid cell growth, differentiation arrest, and blast cell infiltration in the bone marrow and blood. In contrast to CML, ALL does not have the BCR-ABL fusion protein.

C. Myelodysplastic syndromes (MDS) are a group of clonal disorders affecting hematopoietic stem cells, characterized by ineffective hematopoiesis, dysplasia, and increased risk of progression to acute leukemia. While MDS may present with similar symptoms and blood counts, the correct answer is CML due to the specific chromosomal abnormality and BCR-ABL fusion protein.

D. Myelodysplastic syndromes (MDS) are a group of clonal disorders affecting hematopoietic stem cells, characterized by ineffective hematopoiesis, dysplasia, and increased risk of progression to acute